AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oramed Pharmaceuticals Inc.

Major Shareholding Notification May 2, 2023

6965_rns_2023-05-02_2f79af28-5d96-4e14-92fb-8ebc48ebbf5c.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number: 3235-0104
Estimated average burden hours
per response 0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person 2. Date of Event Requiring 3. Issuer Name and Ticker or Trading Symbol
Shapiro Benjamin Statement (Month/Day/Year)
05/01/2023
Oramed Pharmaceuticals Inc. [ORMP]
(Last) (First)
1185 Avenue of the Americas
(Middle) 4. Relationship of Reporting Person(s) to
Issuer
5. If Amendment, Date Original
Filed(Month/Day/Year)
(Street)
New York
NY 10036 X Director
____ Officer (give title
(Check all applicable)
_ 10% Owner
_ Other (specify
6. Individual or Joint/Group Filing (Check
Applicable Line)
(City) (State) (Zip) below)
below)
X
Form filed by One Reporting Person
____ Form filed by More than One
Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
Owned
(Instr. 4)
2. Amount of Securities Beneficially 3. Ownership
Form: Direct (D)
or Indirect (I)
(Instr. 5)
(Instr. 5) 4. Nature of Indirect Beneficial Ownership
Common Stock 1,900,000 I (1)
By trust

Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4. Conversion or
Exercise Price of
Derivative
5. Ownership
Form of
Derivative
6. Nature of Indirect Beneficial
Ownership
(Instr. 5)
Date
Exercisable
Expiration
Date
Title Amount or Number of
Shares
Security Security: Direct
(D) or Indirect (I)
(Instr. 5)

Explanation of Responses:

(1) These shares of common stock are held by a trust of which the reporting person is a trustee and beneficiary.

/s/ Benjamin Shapiro 05/01/2023 **Signature of Reporting Person Date

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Talk to a Data Expert

Have a question? We'll get back to you promptly.